Table 3 Comparison of nephropathy development and laboratory data in patients with type 2 DM

MPO (%)

80 (70–85)

75 (54–88)

88 (78–92)^a

HBA1C (%)

9 (7.1–12)

6.9 (6.15–10.8)

5.4 (5–5.5)^a

Sedimentation (mm/h)

38 ± 21.25

40.39 ± 20.63

26.48 ± 16.45^c

C-reactive protein (g/dl)

3.44 (1.5–7.93)

2.41 (0.99–4.1)

1.38 (0.94–3.63)^e